Qsam Biosciences Inc 's ROA from the fourth quarter of 2023 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Qsam Biosciences Inc 's ROA in the fourth quarter of 2023?
Qsam Biosciences Inc recorded a cumulative net loss of $-5 million during 12 months ending in the fourth quarter of 2023, resulting in a negative return on assets (ROA) of -504.67%.

However, within the Consumer Non Cyclical sector 226 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from 5376 to 5914.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Total Assets Change	367.66 %	-36.79 %	-13.94 %	33.7 %	-78.16 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-5	-6	-6	-6	-6
Return On Assets (TTM)	-504.67 %	-908.66 %	-807.8 %	-794.45 %	-853.9 %
APGR's Total Ranking	# 5914	# 5376	# 5487	# 5626	# 6444
Total Assets (TTM) in million	2	1	0	1	0
Seq. Total Assets Change	179.4 %	31.93 %	-64.15 %	253.86 %	-62.23 %
Seq. Net Income Change	-	-	-	-	-

APGR's 5 Years Annual ROA >> Back to APGR Management Effectiveness >> Compare APGR ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 29
Sector	# 227
Overall	# 5775

Return On Assets Statistics
High	Average	Low
73.11 %	-3294.24 %	-35011.04 %
(Sep 30 2019)		(Dec 31 2020)

Financial Statements
Qsam Biosciences Inc 's Assets	$ 2 million	APGR's Balance sheet
Qsam Biosciences Inc 's Income	$ -1 million	Quarterly APGR's Income Statement
APGR's Income by Division		See APGR's Income by Division

Annual Return On Assets	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019
Y / Y Total Assets Change	367.66 %	-78.16 %	7776.79 %	158.98 %	-94.9 %
Total Assets in million	2	0	2	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-5	-6	-14	-5	-1
Annual Return On Assets	-301.02 %	-1658.41 %	-809.83 %	-22937.18 %	-8331.04 %

APGR's 5 Years Annual ROA >> Back to APGR Management Effectiveness >> Compare APGR ROA to its Competitors

More Return On Assets Ratios
APGR's' Return on Assets at Yahoo Finance
Personal & Household Products Industry Return On Assets Trends and Statistics
Consumer Non Cyclical Sector Roa Statistics
Roa Trends for overall market
APGR's Roa Ratio versus Personal & Household Products Industry, Consumer Non Cyclical Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for APGR's Competitors
Subscribers only: Roa for Qsam Biosciences Inc 's Suppliers
Subscribers only: Return On Assets for APGR's Customers

You may also want to know
APGR's Roi	APGR's Inventory Turnover Ratio	APGR's Growth Rates	APGR's Dividend Comparisons
	APGR's Profitability Ratios	APGR's Asset Turnover Ratio	APGR's Dividend Growth
APGR's Roe	APGR's Valuation Ratios	APGR's Financial Strength Ratios	APGR's Dividend Payout Ratio

Companies with similar Return On Assets at Dec 31 2023, within Consumer Non Cyclical Sector

ROA

Date modified: 2026-08-29T21:39:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.